John R. Downs
Impact in
- Surgery top 0.1%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
Papers in
- Surgery 28
- Lipoproteins and Cardiovascular Health 28
-
- Pneumonia and Respiratory Infections 4
- Co-authors
- Michael B. Clearfield (10 shared papers)Antonio M. Gotto (10 shared papers)Stephen E. Weis (7 shared papers)Alexandra Langendörfer (7 shared papers)Polly A. Beere (6 shared papers)Edwin J. Whitney (6 shared papers)Evan A. Stein (3 shared papers)William B. Kruyer (3 shared papers)
- Journals
- The Lancet (5 papers)JAMA (4 papers)Annals of Internal Medicine (4 papers)The American Journal of Cardiology (3 papers)JAMA Internal Medicine (2 papers)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
John R. Downs
37 papers receiving 10.9k citations
John R. Downs's Hit Papers
Peers
Comparison fields: 5 of 129
- Surgery 7.7k
- Endocrinology, Diabetes and Metabolism 1k
- Family Practice 128
- Cardiology and Cardiovascular Medicine 1.2k
- Geriatrics and Gerontology 103
Countries citing papers authored by John R. Downs
This map shows the geographic impact of John R. Downs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Downs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Downs more than expected).
Fields of papers citing papers by John R. Downs
This network shows the impact of papers produced by John R. Downs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Downs. The network helps show where John R. Downs may publish in the future.
Co-authors
The 25 scholars most cited alongside John R. Downs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels Hit paper breakdown → | 1998 | 4305 |
| 2 | Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials Hit paper breakdown → | 2010 | 1958 |
| 3 | Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events Hit paper breakdown → | 2001 | 1345 |
| 4 | Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins Hit paper breakdown → | 2012 | 667 |
| 5 | Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials Hit paper breakdown → | 2019 | 607 |
| 6 | HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials Hit paper breakdown → | 2014 | 549 |
| 7 | Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Hit paper breakdown → | 2000 | 478 |
| 8 | Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events Hit paper breakdown → | 2014 | 476 |
| 9 | Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials Hit paper breakdown → | 2022 | 182 |
| 10 | 2014 | 144 | |
| 11 | 2012 | 134 | |
| 12 | 2015 | 134 | |
| 13 | 2001 | 119 | |
| 14 | 2015 | 112 | |
| 15 | Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis Hit paper breakdown → | 2024 | 104 |
| 16 | 2001 | 85 | |
| 17 | 1997 | 72 | |
| 18 | 2002 | 53 | |
| 19 | 2020 | 53 | |
| 20 | 1993 | 35 |
About John R. Downs
John R. Downs is a scholar working on Surgery, Epidemiology, Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine and Rheumatology, having authored 37 papers that have together received 11.9k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (28 papers), Pneumonia and Respiratory Infections (4 papers), Metabolism, Diabetes, and Cancer (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Folate and B Vitamins Research (1 paper), Schizophrenia research and treatment (1 paper), Healthcare cost, quality, practices (1 paper) and Acute Myocardial Infarction Research (1 paper). The work is most often cited by research in Surgery (7.7k citations), Endocrinology, Diabetes and Metabolism (1k citations), Family Practice (128 citations), Cardiology and Cardiovascular Medicine (1.2k citations) and Geriatrics and Gerontology (103 citations). John R. Downs has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Michael B. Clearfield, Antonio M. Gotto, Stephen E. Weis, Alexandra Langendörfer, Polly A. Beere, Edwin J. Whitney, Evan A. Stein, William B. Kruyer, Paul M. Ridker and Nader Rifai. Their work appears in journals such as The Lancet, JAMA, Annals of Internal Medicine, The American Journal of Cardiology and JAMA Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.